IL37476A - 6-(1,2,5-thiadiazolyloxyacetyl)-aminopenicillanic acids and their preparation - Google Patents
6-(1,2,5-thiadiazolyloxyacetyl)-aminopenicillanic acids and their preparationInfo
- Publication number
- IL37476A IL37476A IL37476A IL3747671A IL37476A IL 37476 A IL37476 A IL 37476A IL 37476 A IL37476 A IL 37476A IL 3747671 A IL3747671 A IL 3747671A IL 37476 A IL37476 A IL 37476A
- Authority
- IL
- Israel
- Prior art keywords
- acid
- salts
- preparation
- general formula
- stands
- Prior art date
Links
- 239000002253 acid Substances 0.000 title claims description 14
- 238000002360 preparation method Methods 0.000 title claims description 5
- 150000007513 acids Chemical class 0.000 title description 6
- 150000001875 compounds Chemical class 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 4
- 125000000217 alkyl group Chemical group 0.000 claims description 2
- 150000003839 salts Chemical class 0.000 claims 7
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 2
- 229910052739 hydrogen Inorganic materials 0.000 claims 2
- 239000001257 hydrogen Substances 0.000 claims 2
- 239000013543 active substance Substances 0.000 claims 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 1
- 239000007787 solid Substances 0.000 claims 1
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 9
- 239000000243 solution Substances 0.000 description 7
- 239000000203 mixture Substances 0.000 description 6
- 230000002401 inhibitory effect Effects 0.000 description 5
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- 230000035945 sensitivity Effects 0.000 description 4
- 241001660259 Cereus <cactus> Species 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- 150000008064 anhydrides Chemical class 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 229910052740 iodine Inorganic materials 0.000 description 2
- 239000011630 iodine Substances 0.000 description 2
- UWYHMGVUTGAWSP-JKIFEVAISA-N oxacillin Chemical compound N([C@@H]1C(N2[C@H](C(C)(C)S[C@@H]21)C(O)=O)=O)C(=O)C1=C(C)ON=C1C1=CC=CC=C1 UWYHMGVUTGAWSP-JKIFEVAISA-N 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 241000194032 Enterococcus faecalis Species 0.000 description 1
- DNXHEGUUPJUMQT-CBZIJGRNSA-N Estrone Chemical compound OC1=CC=C2[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1 DNXHEGUUPJUMQT-CBZIJGRNSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 241000588653 Neisseria Species 0.000 description 1
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 241000193996 Streptococcus pyogenes Species 0.000 description 1
- 241001312524 Streptococcus viridans Species 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric Acid Chemical compound [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- IYNDLOXRXUOGIU-LQDWTQKMSA-M benzylpenicillin potassium Chemical compound [K+].N([C@H]1[C@H]2SC([C@@H](N2C1=O)C([O-])=O)(C)C)C(=O)CC1=CC=CC=C1 IYNDLOXRXUOGIU-LQDWTQKMSA-M 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 229940093499 ethyl acetate Drugs 0.000 description 1
- 235000019439 ethyl acetate Nutrition 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
- C07D285/10—1,2,5-Thiadiazoles; Hydrogenated 1,2,5-thiadiazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cephalosporin Compounds (AREA)
Description
acids and their preparation GYAfiA 2 The object of the invention is a process for the preparation of new It is known in the art that the derivatives of acid have an effect similar to of natural penicilline Erhart an effect can be considerably influenced by varying the acyl It has been f ound that ne penicillines of the general formula X or a are highly effective i inhibiting the growth of they very which is of great advantage i oral She term is employed here to indicate straight or branched alkyl groups containing from 1 to 4 carbon for example ethyl or propyl The invention relates to novel penioillinee of the general formula I whioh are prepared by reacting nioillanio s o anhydrous m II or a reaotive derivative thereof in the S and X have the same meaning as above and the penioillinee ΘΟ are if in the form of their In a preferable mode of realization of the prooess aooording to the inventio one oan employ the des aoid acid the preferably mixed anhydrides of the acids of the general mula The mixed anhydrides be prepared from arbox acids and aoid As aoid ester one oan emplo J the of aoid as in which case the decomposition of the aoylated duct is carried out in a known manner with water or Acylatiort may be performed in the presence absenoe of bbdiimide euoh as for example or the The acids the substituted in 4 used for the preparation penicillines according to the are new They may be obtained for exnmnle from the known einstook 2823 British Patent Specification 1 154 It has been found that acids of the general formula II may be readily prepared from with carboxylic In the course of these reactions one The novel oompounds according to the invention ve a highly active effect on Their range of antibacterial effect compares with that More all of these compounds have a Iced bacteriostatic effect on gram positive cocci Streptococcus Streptococcus Diplococcus and on gram negative cocci also on gram positive spore bacteria strains Titration of the substances was performed with the as well as with the diffusion The following table indicates the results thus arrived Strains Sensitivity to Penicillines oxacilline 2 3 4 lowest inhibiting conce Streptococcus pyogenes 80 077 S OKI 80 078 S OKI 30 079 S OKI 80 080 S pyog 1 pyog 2 pyog 3 pyog 4 s pyog 5 s Strains Sensitivity to Penicillines 1 2 3 4 lowest inhibiting concent Streptococcus viridans R S 1 s 2 s 3 s 4 s 5 s 31 6 50 7 R Strains Sensitivity to Penicillines 2 3 lowest iniiibiting concentr Streptococcus faecalis Strains Sensitivit to 2 3 lowest conce Diplococc s pneumoniae Strains Sensiti ity to Penicillines 1 3 4 lowest inhibiting concentr Neisseria S S s s s 1 Pharyngo 2 Pharyngo 3 Strains Sensitivity to Penicillines oxacilline 1 2 3 4 lowest inhibiting concentr Cereus bacillus OKI 100 Subtilis R 5 OKI 100 008 Subtilis S OKI 101 020 Subtilis s 6 OKI 101 021 Subtilis s Subtilis S 196S Subtilis S 5 6 25 1969 R Cereus 1 S 12 5 5 Cereus 2 S Subtilis R iations S sensitive fairly sensitive resistent 3 4 o 5 The method according to the invention is described below more particularly the following illustrative 1 EXAMPLE g of tic acid dissolved in dry acetone were treated at with moles of At the same temperature a solution of g of ter in 20 ml of acetone were added dropwise in 5 the reaction mixture was stirred for 20 wherafter the temperature was raised to g of were ded in 15 ml of at and the mixture was dissolved by adding moles of The on so obtained was added the reaction then red for 1 hour in the temperature range of diluted with 120 ml of water and acidified pH 2 by adding 10 ml of n hydrochloric The fiction mixture was ted a mixture 50 ml of ethylacetate and 50 ml of isopropylethe then with ml of The nic phase was washed with 3 x 50 ml of and dried over iodine solution for 10 mg of the Example 2 To a mixture of 50 ml of dry benzene and 5 g of with an of and L in and 1 drop of pyridine a solution of ml of thionylohloride in 10 ml of benzene were added in the course of 30 with After boiling the mixture for 30 the benzene was distilled off at atmospheric and the residual acidic chloride was freed from solvent i g of a yellow oil were g of acid were suspended in 60 mi of water at then dissolved by adding of sodium hydrocarbonate and diluted with 40 ml of The cetone solution of the acide chloride was added to the sodium salt solution dropwise 5 minutes at The the solution was in the range of to 8 by ding some of sodium The solution was then diluted with 50 ml of extracted with 2 x 50 ml of and acidified with 10 ml of 5 phosphoric The racemic acid mixture was extracted with re of 50 of ether and 50 ml of ethyl the organic lodometric analysis showed a consumption of ml of iodine solution for 10 mg of the Example 4 repare of ml 16 insufficientOCRQuality
Claims (1)
1. Claim 1 or a salt as active with organic or solid or liquid Carrie dilutin Human and veterinary pharmaceutical compositions as active agent compounds of the general formula I in Claim insufficientOCRQuality
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HUCI001024 | 1970-08-12 |
Publications (2)
Publication Number | Publication Date |
---|---|
IL37476A0 IL37476A0 (en) | 1971-11-29 |
IL37476A true IL37476A (en) | 1974-10-22 |
Family
ID=10994388
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL37476A IL37476A (en) | 1970-08-12 | 1971-08-09 | 6-(1,2,5-thiadiazolyloxyacetyl)-aminopenicillanic acids and their preparation |
Country Status (10)
Country | Link |
---|---|
US (1) | US3816411A (en) |
AU (1) | AU458881B2 (en) |
BE (1) | BE771236A (en) |
DK (1) | DK132277C (en) |
ES (1) | ES394132A1 (en) |
FR (1) | FR2102209B1 (en) |
GB (1) | GB1319204A (en) |
IL (1) | IL37476A (en) |
NL (1) | NL7111114A (en) |
SE (1) | SE375098B (en) |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB957570A (en) * | 1961-05-03 | 1964-05-06 | Smith Kline French Lab | Heterocyclic antimicrobial agents and processes for their preparation |
-
1971
- 1971-08-09 IL IL37476A patent/IL37476A/en unknown
- 1971-08-10 SE SE7110209A patent/SE375098B/xx unknown
- 1971-08-10 AU AU32174/71A patent/AU458881B2/en not_active Expired
- 1971-08-11 FR FR7129362A patent/FR2102209B1/fr not_active Expired
- 1971-08-11 ES ES394132A patent/ES394132A1/en not_active Expired
- 1971-08-11 DK DK392071A patent/DK132277C/en active
- 1971-08-11 GB GB3776971A patent/GB1319204A/en not_active Expired
- 1971-08-12 BE BE771236A patent/BE771236A/en unknown
- 1971-08-12 NL NL7111114A patent/NL7111114A/xx unknown
- 1971-08-12 US US00171397A patent/US3816411A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
BE771236A (en) | 1971-12-16 |
FR2102209A1 (en) | 1972-04-07 |
SE375098B (en) | 1975-04-07 |
AU3217471A (en) | 1973-02-15 |
AU458881B2 (en) | 1975-03-13 |
GB1319204A (en) | 1973-06-06 |
NL7111114A (en) | 1972-02-15 |
FR2102209B1 (en) | 1975-06-06 |
DK132277C (en) | 1976-04-20 |
IL37476A0 (en) | 1971-11-29 |
US3816411A (en) | 1974-06-11 |
ES394132A1 (en) | 1974-04-01 |
DK132277B (en) | 1975-11-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE1445154C3 (en) | 1,4-Dihydro-1,8-naphthyridinderi derivatives and a process for their preparation | |
NO135777B (en) | ||
SU474974A3 (en) | Method for producing triiodinated α-methyl-dicarboxylic anilides | |
IL37476A (en) | 6-(1,2,5-thiadiazolyloxyacetyl)-aminopenicillanic acids and their preparation | |
US3324135A (en) | 4-alkyl-1-benzo[f]quinolone-2-carboxylic acids | |
FI79544C (en) | FOERFARANDE FOER FRAMSTAELLNING AV PRIMYCINSALTER. | |
GB835737A (en) | Salts of ª-hydroxy-1:2:5:6-tetrahydrobenzylphosphonous acid and a process for their manufacture | |
US3324003A (en) | Method of controlling growth of bacteria using 4-methyl-1-benzo[f]quinolone-2-carboxylic acid | |
US3479401A (en) | Guanidinoaryl and guanidinomethylaryl compounds | |
US3038908A (en) | Novel derivative of the tetracycline antibiotics | |
Tsou et al. | Synthesis of 3-indolyl and 5-bromo-3-indolyl phosphate for histochemical demonstration of alkaline phosphatase | |
US3492291A (en) | Benzyloxycarbonylbenzylpenicillins and their catalytic hydrogenation | |
US3682981A (en) | 2-amino-2-(1,4-cyclohexadienyl) acetic acid | |
US3646218A (en) | Penicillic acid derivatives and related compounds and method of producing them | |
Clark | Deguelin. IV. The Structure of Deguelin and Tephrosin | |
Elliott et al. | 20. Bacteriostasis in the amino-acid series. Part I. Derivatives of alanine | |
SU1226807A1 (en) | Method of producing 2-acetoxy-4-chloro-3,5-diiodobenzanylide | |
JPS5770889A (en) | 1-ethyl-1,8-naphthyridine derivative and salt thereof | |
SU640992A1 (en) | 2-isopropyl-5-methylcyclohexoxy(a,a'-dialkyl)methylpenicillines or their sodium salts possessing antibacterial effect | |
US3476743A (en) | 6-isothiazolylacetamido penicillanic acids | |
Bull et al. | The Cleavage of Carbonyl Compounds by Alkalies. X. Trihalomethylketonic Acids1 | |
Zerban et al. | d-Allulose and Some Methylated Derivatives | |
SU1329142A1 (en) | Mond(asparagin-n)- -dichloromagnesium tetranydrate displaying antispasmatic activity | |
US3278529A (en) | Nitro-furfurylidene acid hydrazides | |
GB1397997A (en) | O-pyrazolo-pyrimidine-thiono-phsophoric -phosphinic- acid esters process for their production and their use as insecticides and acaricides |